Ambio Holdings,
- Business Model
- B2B
- Website
- ambiorx.com
- Last Round
- Corporate RoundJan 2018
- Rounds
- 1
About
Ambio is a peptide active pharmaceutical ingredient (API) contract development and manufacturing organization (CDMO) developing novel peptide drugs and complex generics.
Summary
Ambio Holdings, is a Biotech company based in United States. Its most recent funding was a Corporate Round round in Jan 2018. Investors include The Carlyle Group and MVM Life Science Partners.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2018
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company